![John R. Garrett](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Posizioni attive di John R. Garrett
Società | Posizione | Inizio | Fine |
---|---|---|---|
Glycosyn LLC
![]() Glycosyn LLC Pharmaceuticals: MajorHealth Technology Glycosyn LLC is a biotechnology-based company that develops efficient and cost-effective technologies for synthesizing and producing human milk oligosaccharides (HMOs). The private company is based in Medford, MA. HMOs are major health-giving components of human milk, and Glycosyn owns exclusive rights for methods of manufacturing HMOs as well as for their use in treating inflammatory bowel disease and irritable bowel syndrome, and as prebiotics. Glycosyn Health Initiatives (GHI) is a non-profit dedicated to bringing the benefits of HMOs to those who need them most in the developing world. The CEOs of the company are Howard Newburg, John R. Garrett. | Amministratore Delegato | - | - |
Glycosyn Health Initiatives, Inc. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di John R. Garrett
Precedenti posizioni note di John R. Garrett
Società | Posizione | Inizio | Fine |
---|---|---|---|
ADVANCED PROTEOME THERAPEUTICS CORPORATION | Direttore/Membro del Consiglio | 16/04/2018 | - |
Statistiche
Distribuzione geografica
Stati Uniti | 3 |
Canada | 2 |
Posizioni
Director/Board Member | 2 |
Chief Executive Officer | 1 |
Settori
Health Technology | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
ADVANCED PROTEOME THERAPEUTICS CORPORATION | Health Technology |
Aziende private | 2 |
---|---|
Glycosyn LLC
![]() Glycosyn LLC Pharmaceuticals: MajorHealth Technology Glycosyn LLC is a biotechnology-based company that develops efficient and cost-effective technologies for synthesizing and producing human milk oligosaccharides (HMOs). The private company is based in Medford, MA. HMOs are major health-giving components of human milk, and Glycosyn owns exclusive rights for methods of manufacturing HMOs as well as for their use in treating inflammatory bowel disease and irritable bowel syndrome, and as prebiotics. Glycosyn Health Initiatives (GHI) is a non-profit dedicated to bringing the benefits of HMOs to those who need them most in the developing world. The CEOs of the company are Howard Newburg, John R. Garrett. | Health Technology |
Glycosyn Health Initiatives, Inc. |
- Borsa valori
- Insiders
- John R. Garrett
- Esperienza